Categories AlphaGraphs, Earnings, Health Care

BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the second quarter of 2023.

Biogen Q2 2023 earnings infographic

Total revenue declined 5% year-over-year to $2.46 billion. For the full year of 2023, the company expects revenues to decline in the mid-single digit percentage and projects adjusted earnings per share in the range of $15.00 to 16.00.

Net income attributable to Biogen Inc. was $591.6 million or $4.07 per share in Q2, compared to $1.06 billion or $7.24 per share last year. Adjusted earnings declined 23% to $4.02 per share.

Prior Performance

  • Biogen-Q4-2022-Earnings-Infographic
  • Biogen Q3 2022 earnings infographic
  • Biogen Q2 2022 Earnings Infographic

Most Popular

Key highlights from Carnival Corporation’s (CCL) Q3 2023 earnings results

Carnival Corporation & plc (NYSE: CCL) reported third quarter 2023 earnings results today. Revenues were $6.9 billion compared to $4.3 billion in the same period last year. On a GAAP basis,

NKE Earnings: Here’s everything you need to know about Nike’s Q1 report

Nike, Inc. (NYSE: NKE) on Thursday reported results for the first three months of fiscal 2024, reporting a modest rise in revenues. The sneaker giant reported net income of $1.45

Key takeaways from Accenture’s (ACN) Q4 2023 earnings report

Shares of Accenture plc (NYSE: ACN) were down 4% on Thursday after the company delivered mixed results for the fourth quarter of 2023 and provided full-year guidance that came below

Add Comment
Viewing Highlight